Response to letter regarding article, "Annual rate of transvenous defibrillation lead defects in cardioverter-defibrillators over a period of >10 years" [2]

Circulation

Volumn 116, Issue 18, 2007, Pages

  Kleemann, Thomas ^a   Becker, Torsten ^a   Doenges, Klaus ^a   Vater, Margit ^a   Senges, Jochen ^a   Schneider, Steffen ^a   Saggau, Werner ^a   Weisse, Udo ^a   Seidl, Karlheinz ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DEFIBRILLATION; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; INCIDENCE; LETTER; LIFE EXPECTANCY; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK FACTOR; SHOCK; STROKE; SUDDEN DEATH;

EID: 35648961859     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.187052     Document Type: Letter

References (3)

1. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
2. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
3. Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ, for the MADIT II Investigators. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm. 2006;3:631-637.